Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MBX | SLDE |
|---|---|---|
| Price | $58.54 | $24.14 |
| Change today | ▲ 0.05% | ▲ 2.24% |
| Market cap | $2.82B | $2.82B |
| Return, 3 months | -5.6% | +16.5% |
| Return, year to date | +85.6% | +24.3% |
| Return, 1 year | +260.0% | +51.2% |
| P/E (TTM) | -24.7 | 5.0 |
| P/B | 6.9 | 2.4 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +36.5% |
| Net profit growth (YoY) | – | +120.7% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | 38.4% |
| Return on equity | – | 57.4% |
| Analyst target vs. price | +69.6% | +5.2% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 46 | 55 |
| 30-day volatility | 47.8% | 38.8% |
| Max drawdown, 1 year | -37.6% | -20.0% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
